The effect of chronic treatment with iasenapine and iloperidone on the expression and activity of cytochrome P450 in the brain and liver

2018/31/N/NZ7/01857

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Instytut Farmakologii PAN

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Przemysław Jan Danek

Number of co-investigators in the project: 3

Call

PRELUDIUM 16 – announced on 2018-09-14

Amount awarded
209 720 PLN
Project start date
2019-06-21
Project end date
2023-06-20
Project duration
48 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. 0.
  2. 1.

Information in the final report

Publication in academic press/journals (6)

  1. The Influence of Long-Term Treatment with Asenapine on Liver Cytochrome P450 Expression and Activity in the Rat. The Involvement of Different Mechanisms

    Authors:
    Przemysław Jan Danek, Ewa Bromek, Władysława Anna Daniel
    Academic press:
    Pharmaceuticals (year: 2021, volume: 14(7), pages: 629), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/ph14070629 – link to the publication
  2. The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia

    Authors:
    Przemysław Jan Danek, Władysława Anna Daniel
    Academic press:
    Cells (year: 2022, volume: 11(21), pages: 3513), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/cells11213513 – link to the publication
  3. Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects

    Authors:
    Przemysław Jan Danek, Ewa Bromek, Anna Haduch, Władysława Anna Daniel
    Academic press:
    Neurochemistry International (year: 2021, volume: 151, pages: 105209), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.neuint.2021.105209 – link to the publication
  4. Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms

    Authors:
    Przemysław Jan Danek, Władysława Anna Daniel
    Academic press:
    cells (year: 2021, volume: 10(12), pages: 3472), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/cells10123472 – link to the publication
  5. The Novel Atypical Antipsychotic Lurasidone Affects Cytochrome P450 Expression in the Liver and Peripheral Blood Lymphocytes

    Authors:
    Przemysław Jan Danek, Władysława Anna Daniel
    Academic press:
    International Journal of Molecular Sciences (year: 2023, volume: 23(23), pages: 16796), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms242316796 – link to the publication
  6. The Effect of Chronic Iloperidone Treatment on Cytochrome P450 Expression and Activity in the Rat Liver: Involvement of Neuroendocrine Mechanisms

    Authors:
    Przemysław Jan Danek, Wojciech Kuban, Władysława Anna Daniel
    Academic press:
    International Journal of Molecular Sciences (year: 2021, volume: 22(16), pages: 8447), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms22168447 – link to the publication

Articles in post-conference publications (6)

  1. The effect of chronic treatment with the asenapine on the cytochrome P450 2D (CYP2D) activity in different brain areas

    Authors:
    Danek P.J., Daniel W.A.
    Conference:
    ECNP Workshop for Early Career Scientists in Europe (year: 2020, pages: 46056), Publisher: Elsevier
    Date:
    conference 5-8 Marzec
    Status:
    Published
  2. The effect of chronic treatment with atypical neuroleptic asenapine on the neuroendocrine regulation of liver cytochrome P450

    Authors:
    Danek Przemysław J., Daniel Władysława A.
    Conference:
    4th Central European Biomedical Congress The impact of bioinformatics and omics on biology and medicine (year: 2021, pages: 120), Publisher: CEBC
    Date:
    conference 7-9 czerwiec
    Status:
    Published
  3. Chronic treatment with the atypical neuroleptic asenapine decreases the cytochrome P450 expression and activity in the liver

    Authors:
    Danek P.J., Daniel W.A.
    Conference:
    33rd ECNP Congress Virtual (year: 2020, pages: 383-384), Publisher: Elsevier
    Date:
    conference 12-15 września
    Status:
    Published
  4. Chronic treatment with iloperidone affects the cytochrome P450 2D (CYP2D) protein and activity in the brain and liver

    Authors:
    Przemysław Jan Danek, Władysława Anna Daniel
    Conference:
    34 ECNP Congress (year: 2021, pages: S412), Publisher: European Neuropsychopharmacology
    Date:
    conference 2-5.10.2021
    Status:
    Published
  5. Comparative study on the effects of chronic treatment with the atypical antipsychotic drug lurasidone on cytochrome P450 enzymes in rat liver and lymphocytes

    Authors:
    Danek P.J., Daniel W.A.
    Conference:
    5th Central European Biomedical Congress Future trends in health interventions (year: 2023, pages: 70), Publisher: CEBC
    Date:
    conference 29.05-1.06.2023
    Status:
    Published
  6. The influence of new neuroleptic and antidepressant drugs on brain and liver cytochrome P450 2D (CYP2D)

    Authors:
    Przemysław Jan Danek, Ewa Bromek, Anna Haduch, Władysława Anna Daniel
    Conference:
    22nd INTERNATIONAL CONFERENCE ON CYTOCHROME P450 (year: 2022, pages: 77), Publisher: ICCP450
    Date:
    conference 17-21.07.2022
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski